|
Q3 2021
Filed on Nov 10, 2021
|
4,400
|
$89.5 - $108.81
$394K - $479K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
11,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
7,200
|
$381.76 - $417.47
$2.75M - $3.01M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
71,400
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
285
|
$43.09 - $82.26
$12.3K - $23.4K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
5,500
|
$29.62 - $34.26
$163K - $188K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
10,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
300
|
$125.41 - $143.61
$37.6K - $43.1K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
3,500
|
$28.94 - $34.45
$101K - $121K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
25,400
|
$14.74 - $16.01
$374K - $407K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
8,200
|
$30.6 - $37.46
$251K - $307K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
62,321
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
5,200
|
$220.88 - $250.55
$1.15M - $1.3M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
129,100
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
32,400
|
$29.24 - $36.03
$947K - $1.17M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
10,300
|
$32.47 - $40.15
$334K - $414K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
35,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
44,165
|
$41.82 - $51.87
$1.85M - $2.29M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
53,402
|
$14.07 - $17.3
$751K - $924K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
275,305
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
16,900
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
2,500
|
$30.87 - $47.58
$77.2K - $119K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
3,000
|
$87.4 - $102.73
$262K - $308K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
116,242
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
2,300
|
$39.75 - $44.09
$91.4K - $101K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
5,300
|
$52.44 - $64.7
$278K - $343K
|
|
Constellation Pharmceticls I
|
Q3 2021
Filed on Nov 10, 2021
|
36,404
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
1,100
|
$66.32 - $79.18
$73K - $87.1K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
154,452
|
$10.65 - $14.53
$1.64M - $2.24M
|
|
Boston Private Finl Hldgs In
|
Q3 2021
Filed on Nov 10, 2021
|
223,964
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
4,700
|
$63.69 - $79.54
$299K - $374K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
251,189
|
$7.93 - $10.74
$1.99M - $2.7M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
3,200
|
$10.0 - $13.02
$32K - $41.7K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
1,900
|
$32.69 - $41.29
$62.1K - $78.5K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
2,800
|
$85.77 - $106.43
$240K - $298K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
30,600
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
47,744
|
$23.99 - $38.59
$1.15M - $1.84M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
11,700
|
$26.19 - $29.75
$306K - $348K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
53,400
|
$42.33 - $54.24
$2.26M - $2.9M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
3,700
|
$33.44 - $38.06
$124K - $141K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
17,668
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
26,600
|
$34.05 - $37.85
$906K - $1.01M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
228,607
|
N/A
|
|
New Oriental Ed & Technology
|
Q3 2021
Filed on Nov 10, 2021
|
260,794
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 10, 2021
|
182,821
|
N/A
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
28,200
|
$90.4 - $112.27
$2.55M - $3.17M
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
18,600
|
$30.55 - $36.12
$568K - $672K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
6,100
|
$64.71 - $79.93
$395K - $488K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
19,000
|
$33.96 - $46.16
$645K - $877K
|
|
|
Q3 2021
Filed on Nov 10, 2021
|
68,600
|
$28.46 - $31.63
$1.95M - $2.17M
|
|